Hand Eczema Epidemiology Summary
- Hand eczema is one of the most common inflammatory skin conditions, significantly affecting quality of life and work productivity.
- occupational hand eczema accounts for a substantial proportion of work-related skin diseases, representing nearly 80–90% of all occupational dermatoses in several industrialized countries, particularly among workers exposed to frequent wet work and irritants.
- Epidemiologic studies show a female predominance in most populations, with peak incidence occurring in young to middle adulthood (approximately 20–40 years), largely driven by occupational and irritant exposure patterns.
Hand Eczema Epidemiology Forecast in the 7MM
- 2025 Incident Cases of Hand Eczema: ~XX
- Hand Eczema Growth Rate (2026–2036): XX% CAGR
DelveInsight's ‘Hand Eczema Epidemiology Forecast – 2036’ report delivers an in-depth understanding of the Hand Eczema, historical and forecasted epidemiology, in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
|
Study Period
|
2022–2036
|
|
Historical Year
|
2022–2025
|
|
Forecast Period
|
2026–2036
|
|
Base Year
|
2026
|
|
Geographies Covered
|
ü North America : The US;
ü Europe: Germany, France, Italy, Spain and the UK;
ü Asia-Pacific: Japan
|
|
Hand Eczema Epidemiology CAGR
(Forecast period)
|
XX% (2026–2036)
|
|
Hand Eczema Epidemiology Segmentation Analysis
|
Patient Burden Assessment
· Total Prevalent Cases of Hand Eczema
· Age-specific cases of Hand Eczema
· Gender-Specific Cases of Hand Eczema
· Severity-Specific Cases of Hand Eczema
· Subgroup-Specific Cases of Hand Eczema
|
Hand Eczema Understanding and Diagnosis Algorithm
Hand Eczema Overview and Diagnosis
Hand eczema is a chronic inflammatory skin disorder affecting the hands, characterized by erythema, scaling, vesicles, fissures, and pruritus, and often resulting from a combination of irritant and allergic exposures along with genetic predisposition. It is commonly associated with occupational risk factors, particularly “wet work” involving frequent handwashing and chemical exposure, and shows a higher prevalence among females and working-age adults. Hand eczema can occur independently or in association with atopic dermatitis, with impaired skin barrier function increasing susceptibility. The condition is broadly classified into subtypes such as irritant contact dermatitis, allergic contact dermatitis, and chronic hand eczema, each requiring tailored management. Despite its high prevalence and significant impact on quality of life and productivity, treatment options remain limited, with many patients experiencing recurrent or refractory disease, highlighting a substantial unmet clinical need.
Further details are provided in the report...
Hand Eczema Diagnosis
Diagnosis of hand eczema is based on patient history, clinical examination, and exclusion of differential diagnoses. Key history includes onset, disease course, exposures to irritants/allergens, and atopic dermatitis history. Clinical features include erythema, vesicles, scaling, hyperkeratosis, and fissures, with acute stages showing blistering and exudation and chronic stages showing infiltration and scaling. Common symptoms are pruritus and pain. Patch testing may be used to identify allergens. Early diagnosis is crucial to guide appropriate treatment and prevent chronic disease.
Further details are provided in the report...
Hand Eczema Epidemiology
Key Findings from Hand Eczema Epidemiological Analysis and Forecast
- According to DelveInsight’s estimates, in 2025, the total number of incident cases of Hand eczema in the 7MM were ~XX.
- Epidemiological evidence suggests that hand eczema has an annual prevalence of ~9–10% and a lifetime prevalence of up to ~15%, underscoring its high global disease burden.
- Studies indicate that chronic hand eczema (CHE) represents a smaller subset, yet it accounts for a disproportionate share of severe disease, healthcare utilization, and occupational disability.
- Published literature highlights that occupational exposure particularly “wet work” is a key driver, with healthcare workers, cleaners, and food handlers showing significantly elevated risk and incidence rates.
- The occurrence of hand eczema is 1.5- to 2-fold higher in females than males. The higher prevalence in women is explained by a difference in the distribution of exposure in occupations and private life.
- More than one-third of patients experienced moderate to severe disease and around one-third had a history of atopic dermatitis.
Scope of the Hand Eczema Epidemiology Report
- The report covers a segment of a descriptive overview of hand eczema, explaining their causes, signs and symptoms, and pathogenesis.
- Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of the diagnosis rate, and disease progression.
Hand Eczema Epidemiology Report Insights
- Hand Eczema Patient Population Forecast
Hand Eczema Epidemiology Report Key Strengths
- Epidemiology based (Epi based) Bottom up Forecasting
- 11-year Forecast
- Patient Burden Trends (by geography)
FAQs
- What are the disease risks, burdens, and unmet needs of hand eczema? What will be the growth opportunities across the 7MM concerning the patient population with hand eczema?
- What is the historical and forecasted hand eczema patient pool in the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan?
Reasons to Buy Hand Eczema Epidemiology
- Insights on patient burden/disease prevalence, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
- To understand key opinion leaders’ perspectives around the diagnostic challenges to overcome barriers in the future.
- Detailed insights on various factors hampering disease diagnosis and other existing diagnostic challenges.
1 Key Insights
2 Report Introduction
3 Executive Summary
4 Epidemiology of Hand eczema
5 Hand eczema Patient Burden Overview at a Glance
5.1 Patient Share (%) Distribution by Country in 2025 in the 7MM
5.2 Patient Share (%) Distribution by Country in 2036 in the 7MM
6 Disease Background And Overview of Hand eczema
6.1 Introduction
6.2 Clinical Manifestations
6.3 Etiology and Risk Factors
6.4 Pathophysiology
6.5 Clinical Guidelines
7 Patient Journey of Hand Eczema
8 Epidemiology and Patient Population of Hand Eczema
8.1 Key Findings
8.2 Assumption and Rationale
8.3 Total Prevalent Cases of Hand Eczema in the 7MM
8.4 The United States
8.4.1 Total Prevalent Cases of Hand Eczema in the United States
8.4.2 Age-specific Cases of Hand Eczema in the United States
8.4.3 Gender-specific Cases of Hand Eczema in the United States
8.4.5 Sub-specific Cases of Hand Eczema in the United States
8.4.6 Severity-specific Cases of Hand Eczema in the United States
8.4.7 Total Treated Cases of Hand Eczema in the United States
8.5 EU4 and the UK
8.5.1 Total Prevalent Cases of Hand Eczema in EU4 and the UK
8.5.2 Age-specific Cases of Hand Eczema in EU4 and the UK
8.5.3 Gender-specific Cases of Hand Eczema in EU4 and the UK
8.5.4 Sub-specific Cases of Hand Eczema in EU4 and the UK
8.5.6 Severity-specific Cases of Hand Eczema in the EU4 and the UK
8.5.7 Total Treated Cases of Hand Eczema in the EU4 and the UK
8.6 Japan
8.6.1 Total Prevalent Cases of Hand Eczema in Japan
8.6.2 Age-specific Cases of Hand Eczema in Japan
8.6.3 Gender-specific Cases of Hand Eczema in Japan
8.6.4 Sub-specific Cases of Hand Eczema in Japan
8.6.5 Severity-specific Cases of Hand Eczema in Japan
8.6.6 Total Treated Cases of Hand Eczema in Japan
9 KOL Views of Hand eczema
10 Appendix
10.1 Bibliography
10.2 Report Methodology
11 DelveInsight Capabilities
12 Disclaimer
13 About DelveInsight
List of Tables:
List of Table
Table 1: Summary of Hand Eczema (HE), Epidemiology, and Key Events (2021-2034)
Table 2: Classification of Hand Eczema
Table 3: Definition of Subtypes of Hand Eczema
Table 4: Etiological Classification of Hand Eczema
Table 5: Morphological classification of Hand Eczema
Table 6: Subgroups of hand eczema and definitions
Table 7: Besides Atopic Skin Diathesis, Other Genetic Risk Factors for Hand Dermatitis Have Been Suggested
Table 8: Summary of Recommendations for the Diagnosis of HE
Table 9: Summary of Recommendations for the Treatment of HE
Table 10: Summary of Recommendations of Topical Corticosteroids for the Treatment of HE
Table 11: Summary of Recommendations of Topical Calcineurin Inhibitors for the Treatment of HE
Table 12: Summary of Recommendations for Photo-therapy for the Treatment of HE
Table 13: Summary of Recommendations of Systemic Treatment for the Treatment of HE
Table 14: Summary of Recommendations for the prevention of HE
Table 15: Total Prevalent Population of Hand Eczema in 7MM (2021-2034)
Table 16: Total Prevalent Cases of Hand Eczema in the US (2021-2034)
Table 17: Gender-specific Cases of Hand Eczema in the US (2021-2034)
Table 18: Severity-specific Cases of Hand Eczema in the US (2021-2034)
Table 19: Subgroup-specific Cases of Hand Eczema in the US (2021-2034)
Table 20: Age-specific Cases of Hand Eczema in the US (2021-2034)
Table 21: Total Prevalent Cases of Hand Eczema in EU-5 (2021-2034)
Table 22: Gender-Specific Cases of Hand Eczema in Germany, (2021-2034)
Table 23: Severity-specific Cases of Hand Eczema in Germany, (2021-2034)
Table 24: Subgroup-specific Cases of Hand Eczema in Germany, (2021-2034)
Table 25: Age-specific Cases of Hand Eczema in Germany (2021-2034)
Table 26: Gender-specific Cases of Hand Eczema in the France (2021-2034)
Table 27: Severity-specific Cases of Hand Eczema in the France (2021-2034)
Table 28: Subgroup-specific Cases of Hand Eczema in the France, (2021-2034)
Table 29: Age-specific Cases of Hand Eczema in the France, (2021-2034)
Table 30: Gender-specific Cases of Hand Eczema in Italy (2021-2034)
Table 31: Severity-specific Cases of Hand Eczema in Italy (2021-2034)
Table 32: Subgroup-specific Cases of Hand Eczema in Italy (2021-2034)
Table 33: Age-specific Cases of Hand Eczema in Italy (2021-2034)
Table 34: Gender-specific Cases of Hand Eczema in Spain (2021-2034)
Table 35: Severity-specific Cases of Hand Eczema in Spain (2021-2034)
Table 36: Subgroup-specific Cases of Hand Eczema in Spain (2021-2034)
Table 37: Age-specific Cases of Hand Eczema in Spain (2021-2034)
Table 38: Gender-specific Cases of Hand Eczema in the UK (2021-2034)
Table 39: Severity-specific Cases of Hand Eczema in the UK, (2021-2034)
Table 40: Subgroup-specific Cases of Hand Eczema in the UK (2021-2034)
Table 41: Age-specific Cases of Hand Eczema in the UK (2021-2034)
Table 42: Total Prevalent Cases of Hand Eczema in Japan (2021-2034)
Table 43: Gender-specific Cases of Hand Eczema in Japan (2021-2034)
Table 44: Severity-specific Cases of Hand Eczema in Japan (2021-2034)
Table 45: Subgroup-specific Cases of Hand Eczema in Japan (2021-2034)
Table 46: Age-specific Cases of Hand Eczema in Japan (2021-2034)
List of Figures:
List of Figures
Figure 1: Risk Factors for the Development of Hand Eczema
Figure 2: Etiologic diagnosis of Hand Eczema
Figure 3: Treatment options for hand eczema depending on disease severity and chronicity (based on probable efficacy, not strength of evidence)
Figure 4: Treatment algorithm for hand eczema
Figure 5: Total Prevalent Population of Hand Eczema (2021-2034)
Figure 6: Total Prevalent Cases of Hand Eczema in the US (2021-2034)
Figure 7: Gender-specific Cases of Hand Eczema in the US (2021-2034)
Figure 8: Severity-specific Cases of Hand Eczema in the US (2021-2034)
Figure 9: Subgroup-specific Cases of Hand Eczema in the US (2021-2034)
Figure 10: Age-specific Cases of Hand Eczema in the US (2021-2034)
Figure 11: Total Prevalent Cases of Hand Eczema in the EU-5 (2021-2034)
Figure 12: Gender-specific Cases of Hand Eczema in Germany (2021-2034)
Figure 13: Severity-specific Cases of Hand Eczema in Germany (2021-2034)
Figure 14: Subgroup-specific Cases of Hand Eczema in Germany (2021-2034)
Figure 15: Age-specific Cases of Hand Eczema in Germany (2021-2034)
Figure 16: Gender-specific Cases of Hand Eczema in the France (2021-2034)
Figure 17: Severity-specific Cases of Hand Eczema in the France (2021-2034)
Figure 18: Subgroup-specific Cases of Hand Eczema in the France (2021-2034)
Figure 19: Age-specific Cases of Hand Eczema in the France (2021-2034)
Figure 20: Gender-specific Cases of Hand Eczema in Italy (2021-2034)
Figure 21: Severity-specific Cases of Hand Eczema in Italy (2021-2034)
Figure 22: Subgroup-specific Cases of Hand Eczema in Italy (2021-2034)
Figure 23: Age-specific Cases of Hand Eczema in Italy (2021-2034)
Figure 24: Gender-specific Cases of Hand Eczema in Spain (2021-2034)
Figure 25: Severity-specific Cases of Hand Eczema in Spain (2021-2034)
Figure 26: Subgroup-specific Cases of Hand Eczema in Spain (2021-2034)
Figure 27: Age-specific Cases of Hand Eczema in Spain (2021-2034)
Figure 28: Gender-specific Cases of Hand Eczema in the UK (2021-2034)
Figure 29: Severity-specific Cases of Hand Eczema in the UK (2021-2034)
Figure 30: Subgroup-specific Cases of Hand Eczema in the UK (2021-2034)
Figure 31: Age-specific Cases of Hand Eczema in the UK (2021-2034)
Figure 32: Total Prevalent Cases of Hand Eczema in Japan (2021-2034)
Figure 33: Gender-specific Cases of Hand Eczema in Japan (2021-2034)
Figure 34: Severity-specific Cases of Hand Eczema in Japan (2021-2034)
Figure 35: Subgroup-specific Cases of Hand Eczema in Japan (2021-2034)
Figure 36: Age-specific Cases of Hand Eczema in Japan (2021-2034)
-market-Goutieres-Syndrome.png&w=256&q=75)
